دانلود کتاب لیپیدولوژی بالینی: همراه بیماری قلبی براون والد
Clinical Lipidology: A Companion to Braunwald’s Heart Disease, 2ed

Clinical Lipidology, a companion to Braunwald’s Heart Disease, is designed to guide you through the ever-changing therapeutic management of patients with high cholesterol levels. From basic science to pathogenesis of atherothrombotic disease, to risk assessment and the latest therapy options, this medical reference book offers unparalleled coverage and expert guidance on lipidology in a straightforward, accessible, and user-friendly style.

• Get authoritative guidance from some of the foremost experts in the field.
• Easily access key content with help from treatment algorithms.

• Access options and evidence-based solutions for every type of patient scenario, as well as the latest clinical guidelines and clinically relevant evidence on risk assessment, special patient populations, and therapy, including recently approved and experimental therapies.
• Remain at the forefront of the cardiology field with up-to-date chapters on treatment guidelines; diet, exercise, and weight loss; pharmacologic therapies such as statins, omega-3 fatty acids, and combination therapy; evolving targets of therapy such as PCSK9 inhibition, CETP inhibition, and inflammation
• Prepare for special patient populations such as children and adolescents; women and the elderly; transplant recipients; HIV patients; and those with chronic renal disease, familial hypercholesterolemia, other severe hypercholesterolemias, diabetes, or other metabolic syndromes.
• Take advantage of a format that follows that of the well-known and internationally recognized Braunwald’s Heart Disease.
• Expert Consult eBook version included with purchase.

Review

“This book upholds the high standards that would be expected of a companion to Braunwald’s Heart Disease. It is easy to read, yet provides an in-depth understanding of lipid disorders…This book is directed at medical students, midlevel providers, physicians in training, and practicing clinicians who require a thorough understanding of dyslipidemia. It would be a welcome addition to the library of anyone focused on preventive medicine and the treatment of patients with dyslipidemia.” – Doody’s ***

Contents

Section 1 Basic Mechanisms

۱. Human Plasma Lipoprotien Metabolism

۲. Regulation and Clearance of Apolipoprotein B-Containing Lipoproteins

۳. Absorption and Excretion of Intestinal Cholesterol and Other Sterols

۴. High-Density Lipoprotein Metabolism

۵. Lipoproteins: Mechanisms for Atherogenesis and Progression of Atherothrombotic Disease

۶. Impact of Rare and Common Genetic Variants on Lipoprotein Metabolism

۷. Lipoprotein Oxidation: Mechanisms and Biotheranostic Applications

Section 2 Risk Assessment

۸. Cholesterol: Concentration, Ratio, and Particle Number

۹. High-Density Lipoprotein Cholesterol and Triglycerides in Coronary Heart Disease Risk Assessment

۱۰. Lipoprotein(a)

۱۱. Clinical Evaluation for Genetic and Secondary Causes of Dyslipidemia

۱۲. Use of High Sensitivity C-Reactive Protein for Risk Assessment

۱۳. Role of Lipoprotein-Associated Phospholipase A2 in Vascular Disease

۱۴. Emerging Assays

۱۵. Imaging Atherosclerosis for Risk Stratification by Cardiac Computed Tomography or Carotid Ultrasound

Section 3 Therapy

۱۶. Overview of General Approach to Management of Elevated Low-Density Lipoprotein Cholesterol and Mixed Dyslipidemia, High Triglycerides, and Low High-Density Lipoprotein Cholesterol

۱۷. Treatment Guidelines Overview

۱۸. Dietary Patterns for the Prevention and Treatment of Cardiovascular Disease

۱۹. Exercise and Lipids

۲۰. Weight Loss

۲۱. Statins

۲۲. Bile Acid Sequestrants

۲۳. Cholesterol Absorption Inhibitors

۲۴. Niacin (Nicotinic Acid)

۲۵. Fibrates

۲۶. Omega-3 Fatty Acids

۲۷. Combination Therapy for Dyslipidemia

۲۸. Nutriceuticals and Functional Foods for Cholesterol Reduction

۲۹. Evolving Targets of Therapy: Cholesteryl Ester Transfer Protein Inhibition

۳۰. Evolving Targets of Therapy: Proprotein Convertase Subtilisin/Kexin 9 Inhibition

۳۱. Evolving Targets of Therapy: Inflammation as a Method to Predict and Prevent Cardiovascular Events

۳۲. Invasive Imaging Modalities and Atherosclerosis: Intravascular Ultrasound

۳۳. Noninvasive Imaging Modalities and Atherosclerosis: The Role of Ultrasound

۳۴. Noninvasive Imaging Modalities and Atherosclerosis: The Role of Magnetic Resonance Imaging and Positron Emission Tomography Imaging

۳۵. Special Patient Populations: Diabetes and Metabolic Syndrome

۳۶. Special Patient Populations: Women and Elderly

۳۷. Special Patient Populations: Children and Adolescents

۳۸. Special Patient Populations: Familial Hypercholesterolemia and other Severe Hypercholesterolemias

۳۹. Special Patient Populations: Acute Coronary Syndromes

۴۰. Special Patient Populations: Transplant Recipients

۴۱. Special Patient Populations: Chronic Kidney Disease

۴۲. Special Patient Populations: Lipid Abnormalities in High-Risk Ethnic Groups

۴۳. Special Patient Populations: Human Immunodeficiency Patients

۴۴. Therapeutic Targeting of High-Density Lipoprotein Metabolism

نسخه اصلی همراه با بوک مارک کامل